Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Gullestad

Showing results (171-180 of 382) with videos related to

Pageof 39
Sort By:
Current Atherosclerosis Reports|May 21, 2008
The complex role of T-cell-based immunity in atherosclerosisPål Aukrust, Kari Otterdal, Arne Yndestad, et al.
Journal of the American College of Cardiology|January 18, 2005
What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF)Lars Gullestad, John Wikstrand, Prakash Deedwania, et al.
Journal of Diabetes|October 29, 2014
Identification of a definite diabetic cardiomyopathy in type 2 diabetes by comprehensive echocardiographic evaluation: A cross-sectional comparison with non-diabetic weight-matched controlsAnne Pernille Ofstad, Stig Urheim, Håvard Dalen, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 21, 2020
Mild acute cellular rejection and development of cardiac allograft vasculopathy assessed by intravascular ultrasound and coronary angiography in heart transplant recipients-a SCHEDULE trial substudyLaerke Marie Nelson, Arne Kristian Andreassen, Satish Arora, et al.
Journal of Diabetes and Its Complications|August 26, 2023
Changes in cardiac and vascular haemodynamics as potential mediators of improvements in cardiovascular and kidney outcomes with empagliflozin in type 2 diabetesBernhard K Krämer, Sibylle J Hauske, Robert Chilton, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|June 22, 2016
Low YKL-40 in chronic heart failure may predict beneficial effects of statins: analysis from the controlled rosuvastatin multinational trial in heart failure (CORONA)Fizza Arain, Lars Gullestad, Ståle Nymo, et al.
Circulation. Heart Failure|November 29, 2013
Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trialJørgen Gravning, Erik T Askevold, Ståle H Nymo, et al.
Scandinavian Cardiovascular Journal : SCJ|June 22, 2016
Patient characteristics and risk factors of participants and non-participants in the NOR-COR studyJohn Munkhaugen, Elise Sverre, Kari Peersen, et al.
Clinical Transplantation|November 8, 2021
A randomized clinical study using optical coherence tomography to evaluate the short-term effects of high-intensity interval training on cardiac allograft vasculopathy: a HITTS substudyMuzammil Rafique, Ole Geir Solberg, Lars Gullestad, et al.
Lipids in Health and Disease|December 31, 2011
Krill oil attenuates left ventricular dilatation after myocardial infarction in ratsLinn E Fosshaug, Rolf K Berge, Jan O Beitnes, et al.
Pageof 39

Showing results (171-180 of 382) with videos related to

Sort By:
Pageof 39
Current Atherosclerosis Reports|May 21, 2008
The complex role of T-cell-based immunity in atherosclerosisPål Aukrust, Kari Otterdal, Arne Yndestad, et al.
Journal of the American College of Cardiology|January 18, 2005
What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF)Lars Gullestad, John Wikstrand, Prakash Deedwania, et al.
Journal of Diabetes|October 29, 2014
Identification of a definite diabetic cardiomyopathy in type 2 diabetes by comprehensive echocardiographic evaluation: A cross-sectional comparison with non-diabetic weight-matched controlsAnne Pernille Ofstad, Stig Urheim, Håvard Dalen, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 21, 2020
Mild acute cellular rejection and development of cardiac allograft vasculopathy assessed by intravascular ultrasound and coronary angiography in heart transplant recipients-a SCHEDULE trial substudyLaerke Marie Nelson, Arne Kristian Andreassen, Satish Arora, et al.
Journal of Diabetes and Its Complications|August 26, 2023
Changes in cardiac and vascular haemodynamics as potential mediators of improvements in cardiovascular and kidney outcomes with empagliflozin in type 2 diabetesBernhard K Krämer, Sibylle J Hauske, Robert Chilton, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|June 22, 2016
Low YKL-40 in chronic heart failure may predict beneficial effects of statins: analysis from the controlled rosuvastatin multinational trial in heart failure (CORONA)Fizza Arain, Lars Gullestad, Ståle Nymo, et al.
Circulation. Heart Failure|November 29, 2013
Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trialJørgen Gravning, Erik T Askevold, Ståle H Nymo, et al.
Scandinavian Cardiovascular Journal : SCJ|June 22, 2016
Patient characteristics and risk factors of participants and non-participants in the NOR-COR studyJohn Munkhaugen, Elise Sverre, Kari Peersen, et al.
Clinical Transplantation|November 8, 2021
A randomized clinical study using optical coherence tomography to evaluate the short-term effects of high-intensity interval training on cardiac allograft vasculopathy: a HITTS substudyMuzammil Rafique, Ole Geir Solberg, Lars Gullestad, et al.
Lipids in Health and Disease|December 31, 2011
Krill oil attenuates left ventricular dilatation after myocardial infarction in ratsLinn E Fosshaug, Rolf K Berge, Jan O Beitnes, et al.
Pageof 39